The Efficacy of Platelet Rich Plasma and Prolotherapy in Chondromalacia Patella Treatment

Objective: Chondromalacia patella (CMP) is a frequently seen musculoskeletal disorder. Platelet-rich plasma (PRP) is considerably useful in sports injuries. Prolotherapy (PrT) is a regenerative injection technique used in chronic musculoskeletal disorders. The aim of this study is to compare PRP and PrT therapies in CMP treatment. Materials and Methods: Seventy five patients with CMP symptoms refractory to three months of conservative treatment methods were included in this study. The patients were divided into PRP (n=38) and PrT (n=37) groups. A questionnaire has been applied, VAS scores, Tegner and Lysholm knee scores (TLS) were obtained. They were repeated three, six weeks after the beginning of treatment, and 12 months following the treatment. A standard 12-week exercise program was prescribed to all of the patients. Results: Pain and knee functions improved significantly after a minimum one year of follow-up in both groups (p˂0.05). However, PRP was superior to PrT in terms of pain level during exercise, range of motion, crepitus, total number of medications, VAS and TLS (p=0.004, p=0.038, p˂0.001, p=0.003, p=0.001 and p=0.026 respectively). Conclusions: PRP and PrT therapies applied with exercise were shown to be effective in CMP treatment; however PRP therapy seems to be more effective than PrT.

Kondromalazi Patella Tedavisinde Trombositten Zengin Plazma ve Proloterapinin Etkisi

Amaç: Kondromalazi patella (CMP), sık görülen bir kas-iskelet sistemi hastalığıdır. Trombositten zengin plazmanın (PRP), spor yaralanmalarında önemli ölçüde faydalı olduğu bilinmektedir. Proloterapi (PrT) ise, kronik kas-iskelet sistemi hastalıkları için kullanılan rejeneratif bir enjeksiyon tekniğidir. Bu çalışmanın amacı, CMP tedavisinde PRP ve PrT tedavilerinin etkinliğini karşılaştırmaktır. Gereç ve Yöntemler: Üç ay süren konservatif tedaviye dirençli yetmiş beş CMP hastası çalışmaya alındı. Hastalar randomize olarak PRP veya PrT grupları olarak iki gruba ayrıldı. Hasta sorgulama anketi, VAS, Tegner ve Lysholm diz skorları (TLS) uygulandı. Bunlar tedavinin başlangıcından üç, altı hafta sonra ve tedaviden 12 ay sonra tekrarlandı. Tüm hastalara 12 haftalık standart egzersiz programı verildi. Bulgular: Her iki grubun da ağrı ve diz fonksiyonları bir yıllık izlemden sonra belirgin olarak düzeldi (p


1. Mori Y, Kubo M, Okumo H, et al. Histological comparison of patellar cartilage degeneration between chondromalacia in youth and osteoarthritis in aging. Knee Surg Sports Traumatol Arthrosc. 1995;3(3):167-72.

2. Brukner P. Anterior knee pain. In: Crossley K, Cook J, Cowan S, McConnell J, Eds. Brukner& Kahn’s Clinical Sports Medicine. 4th ed. Australia: McGraw-Hill, 2012. pp. 689-700.

3. Kettunen JA, Visuri T, Harilainen A, et al. Primary cartilage lesions and outcome among subjects with patellofemoral pain syndrome. Knee Surg Sports Traumatol Arthrosc. 2005;13(2):131-4.

4. Eriksson E. Treatment of deep chondral defects of the patella. Knee Surg Sports Traumatol Arthrosc. 2005;13(5):345.

5. Houglum PA. Functional and Activity-Spesfic Exercise. In: Therapeutic Exercise for Musculoskeletal Injuries. 3rd ed. Pittsburg: Human Kinetics Publishers, 2010. pp. 295-319.

6. Kon E, Filardo G. PRP or not PRP? That is the question. Knee Surg Sports Traumatol Arthrosc. 2011;19(6):870- 1.

7. Nguyen RT, Borg-Stein J, McInnis K. Applications of platelet-rich plasma in musculoskeletal and sports medicine: an evidence-based approach. PM R. 2011;3(3):226-50.

8. Filardo G, Kon E, Di Matteo A, et al. Platelet-rich plasma vs hyaluronic acid to treat knee degenerative pathology: study design and preliminary results of a randomized controlled trial. BMC Musculoskelet Disord. 2012;13:229.

9. Gobbi A, Lad D, Karnatzikos G. The effects of repeated intra-articular PRP injections on clinical outcomes of early osteoarthritis of the knee. Knee Surg Sports Traumatol Arthrosc. 2015;23(8):2170-7.

10. Orscelik A, Yildiz Y. Comparison of single and triple platelet rich plasma injections in the treatment of patellofemoral pain syndrome. Turkiye Klinikleri J Med Sci. 2015;35(2):78-87.

11. Sánchez M, Fiz N, Azofra J, et al. A randomized clinical trial evaluating plasma rich in growth factors (PRGFEndoret) versus hyaluronic acid in the short-term treatment of symptomatic knee osteoarthritis. Arthroscopy. 2012;28(8):1070-8.

12. Spaková T, Rosocha J, Lacko M, et al. Treatment of knee joint osteoarthritis with autologous platelet-rich plasma in comparison with hyaluronic acid. Am J Phys Med Rehabil. 2012;91(5):411-7.

13. Akpancar S, Seven MM, Tuzun HY, et al. Current concepts of prolotherapy in orthopedic surgery. Arch Trauma Res. 2017;6(2):e40447.

14. Martins CAQ, Bertuzzi RT, Tisot RA, et al. Dextrose prolotherapy and corticosteroid injection into rat Achilles tendon. Knee Surg Sports Traumatol Arthrosc. 2012;20(10):1895-900.

15. Rabago D, Lee KS, Ryan M, et al. Hypertonic dextrose and morrhuate sodium injections (prolotherapy) for lateral epicondylosis (tennis elbow): results of a single- blind, pilot-level, randomized controlled trial. Am J Phys Med Rehabil. 2013;92(7):587-96.

16. Seven MM, Ersen O, Akpancar S, et al. Effectiveness of prolotherapy in the treatment of chronic rotator cuff lesions. Orthop Traumatol Surg Res. 2017;103(3):427- 33.

17. Solmaz I, Orscelik A. Features and Clinical Effectiveness of the Regenerative Injection Treatments: Prolotherapy and Platelet-Rich Plasma for Musculoskeletal Pain Management. In: From Conventional to Innovative Approaches for Pain Treatment. 1 st ed. IntechOpen; 2019. DOI: 10.5772/intechopen.84580

18. Carayannopoulos A, Borg-Stein J, Sokolof J, et al. Prolotherapy versus corticosteroid injections for the treatment of lateral epicondylosis a randomized controlled trial. PM R. 2011;3(8):706-15.

19. Yildiz Y, Apaydin AH, Seven MM, et al. The effects of prolotherapy (hypertonic dextrose) in recreational athletes with patellofemoral pain syndrome. J Exp Integr Med. 2016;6(2):53-6.

20. Murphy M, Godson C, Cannon S, et al. Suppression subtractive hybridization identifies high glucose levels as a stimulus for expression of connective tissue growth factor and other genes in human mesangial cells. J Biol Chem. 1999;274(9):5830-4.

21. McCauley TR, Kier R, Lynch KJ, et al. Chondromalacia patellae: diagnosis with MR imaging. AJR Am J Roentgenol. 1992;158(1):101-5.

22. Niskanen RO, Paavilainen PJ, Jaakkola M, et al. Poor correlation of clinical signs with patellar cartilaginous changes. Arthroscopy. 2001;17(3):307-10.

23. Sweitzer BA, Cook C, Steadman JR, et al. The interrater reliability and diagnostic accuracy of patellar mobility tests in patients with anterior knee pain. Phys Sportsmed. 2010;38(3):90-6.

24. Hauser RA, Sprague IS. Outcomes of prolotherapy in chondromalacia patella patients: improvements in pain level and function. Clin Med Insights Arthritis Musculoskelet Disord. 2014;7:13-20.

25. Çelik D, Coşkunsu D, Kılıçoğlu Ö. Translation and cultural adaptation of the Turkish Lysholm Knee Scale: ease of use, validity and reliability. Clin Orthop Relat Res. 2013; 471(8):2602-10.

26. Hackett GS, Hemwall GA, Montgomery GA editors. Ligaments and tendon relaxation treated by prolotherapy. 5th ed. USA Hackett Hemwall Foundation;2008.

27. Linetsky FS, Rafael M, Saberski L. Pain management with regenerative injection therapy (RIT). In: Weiner RS, Ed. Pain Management: a Practical Guide for Clinicians. 6th ed. Washington, DC: CRC Press, American Academy of Pain Management, 2002. pp. 381-402.

28. Rabago D, Mundt M, Zgierska A, et al. Hypertonic dextrose injection (prolotherapy) for knee osteoarthritis: Long term outcomes. Complement Ther Med. 2015;23(3),388-95.

29. Reeves KD, Hassanein KM. Long-term effects of dextrose prolotherapy for anterior cruciate ligament laxity. Altern Ther Health Med. 2003;9(3):58-62.

30. Milano G, Sanna Passino E, Deriu L, et al. The effect of platelet rich plasma combined with microfractures on the treatment of chondral defects: an experimental study in a sheep model. Osteoarthritis Cartilage. 2010;18(7):971-80.

31. Kon E, Mandelbaum B, Buda R, et al. Platelet-rich plasma intra-articular injection versus hyaluronic acid viscosupplementation as treatments for cartilage pathology: from early degeneration to osteoarthritis. Arthroscopy. 2011;27(11):1490-501.

32. Dhurat R, Sukesh MS. Principles and methods of preparation of platelet-rich plasma: a review and author's perspective. J Cutan Aesthet Surg. 2014;7(4),189-97.

33. Lhee SH, Kim JW, Jeon JB, et al. Comparison of laboratory data among the six different prp separation systems using 144 samples. Br J Sports Med. 2016;50(22), e4.9-e4.

34. Görmeli G, Görmeli CA, Ataoglu B, et al. Multiple PRP injections are more effective than single injections and hyaluronic acid in knees with early osteoarthritis: a randomized, double-blind, placebo-controlled trial. Knee Surg Sports Traumatol Arthrosc. 2017;25(3):958- 65.

35. Dursun N, Dursun E, Kiliç Z. Electromyographic biofeedback- controlled exercise versus conservative care for patellofemoral pain syndrome. Arch Phys Med Rehabil. 2001;82(12):1692-5.

36. Hazneci B, Yildiz Y, Şekir U, et al. Efficacy of isokinetic exercise on joint position sense and muscle strength in patellofemoral pain syndrome. Am J Phys Med Rehabil. 2005;84(7):521-7.

37. Yildiz Y, Aydin T, Sekir U, et al. Relation between isokinetic muscle strength and functional capacity in recreational athletes with chondromalacia patellae. Br J Sports Med. 2003;37(6):475-9.

38. Di Matteo B, Filardo G, Kon E. Platelet-rich plasma: evidence for the treatment of patellar and Achilles tendinopathy- a systematic review. Musculoskelet Surg. 2015;99(1):1-9.

39. Virchenko O, Aspenberg P. How can one platelet injection after tendon injury lead to a stronger tendon after 4 weeks? Interplay between early regeneration and mechanical stimulation. Acta Orthop. 2006;77(5):806- 12.

Kaynak Göster